| Jessica Savidge Rose, CRNA | |
|
145 Kimel Park Dr Ste 120, Winston Salem, NC 27103 | |
| (336) 768-3212 | |
| (336) 768-9019 |
| Full Name | Jessica Savidge Rose |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 145 Kimel Park Dr Ste 120, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023418373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 224696 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Forsyth Medical Center | Winston-salem, NC | Hospital |
| Novant Health Medical Park Hospital | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Park Hospital Llc | 4880595958 | 77 |
| Forsyth Memorial Hospital Inc | 9537071790 | 531 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Novant Health Thomasville Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033160205 PECOS PAC ID: 5890605224 Enrollment ID: O20031222000916 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Medical Park Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003867516 PECOS PAC ID: 4880595958 Enrollment ID: O20040120000968 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Forsyth Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104548874 PECOS PAC ID: 9537071790 Enrollment ID: O20040405001702 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Novant Health Rowan Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508931544 PECOS PAC ID: 3375452519 Enrollment ID: O20040422001655 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Piedmont Triad Anesthesia, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467497081 PECOS PAC ID: 8426020025 Enrollment ID: O20040824000312 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Novant Health Matthews Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Presbyterian Sameday Surgery Center At Ballantyne Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215061049 PECOS PAC ID: 4587759949 Enrollment ID: O20070928000739 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Presbyterian Sameday Surgery Center At Huntersville Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1063641801 PECOS PAC ID: 8426197971 Enrollment ID: O20100521000450 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Brunswick Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669725198 PECOS PAC ID: 9335150895 Enrollment ID: O20130903000403 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Novant Health Kernersville Outpatient Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1750892659 PECOS PAC ID: 3870858525 Enrollment ID: O20180530000007 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Novant Health Mint Hill Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063910404 PECOS PAC ID: 8123374394 Enrollment ID: O20181018000540 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Entity Name | Novant Health Clemmons Outpatient Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1528521887 PECOS PAC ID: 6103154778 Enrollment ID: O20190820003091 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Savidge Rose, CRNA 145 Kimel Park Dr Ste 120, Winston Salem, NC 27103-6983 Ph: (336) 768-3212 | Jessica Savidge Rose, CRNA 145 Kimel Park Dr Ste 120, Winston Salem, NC 27103 Ph: (336) 768-3212 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, "Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?" [IP21], at ISPOR 2018 in Baltimore, MD, USA.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.
› Verified 4 days ago
Nicholas Ryan Tuttle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-409-1797 | |
Yetta Hardy Clark, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 145 Kimel Park Dr, Suite 300, Winston Salem, NC 27103 Phone: 336-768-3212 Fax: 336-768-9019 | |
Carie Sue Nunley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 145 Kimel Park Dr, Suite 120, Winston Salem, NC 27103 Phone: 336-768-3212 Fax: 336-768-9019 | |
Connie Sue Freeman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 145 Kimel Park Dr Ste 120, Winston Salem, NC 27103 Phone: 336-768-3212 Fax: 336-768-9019 | |
Charlie Martin Robertson Iii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2011 | |
Holly C Pegram, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 145 Kimel Park Dr, Suite 120, Winston Salem, NC 27103 Phone: 336-768-3212 Fax: 336-768-9019 |